These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8126697)

  • 1. Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety.
    Portoghese PS; Sultana M; Moe ST; Takemori AE
    J Med Chem; 1994 Mar; 37(5):579-85. PubMed ID: 8126697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.
    Gao P; Larson DL; Portoghese PS
    J Med Chem; 1998 Jul; 41(16):3091-8. PubMed ID: 9685249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands.
    Fang X; Larson DL; Portoghese PS
    J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of peptidomimetic delta opioid receptor antagonists using the message-address concept.
    Portoghese PS; Sultana M; Takemori AE
    J Med Chem; 1990 Jun; 33(6):1714-20. PubMed ID: 2160538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-Arylidenenaltrexones as selective delta1 opioid receptor antagonists.
    Ohkawa S; Portoghese PS
    J Med Chem; 1998 Oct; 41(21):4177-80. PubMed ID: 9767654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and delta-opioid receptor antagonist activity of a naltrindole analogue with a regioisomeric indole moiety.
    Portoghese PS; Ohkawa S; Moe ST; Takemori AE
    J Med Chem; 1994 Jun; 37(12):1886-8. PubMed ID: 8021929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-Desoxy analogues of naltrindole and 7-spiroindanyloxymorphone: the role of the 14-hydroxy group at delta opioid receptors.
    Kshirsagar TA; Fang X; Portoghese PS
    J Med Chem; 1998 Jul; 41(14):2657-60. PubMed ID: 9651172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors.
    Ohkawa S; DiGiacomo B; Larson DL; Takemori AE; Portoghese PS
    J Med Chem; 1997 May; 40(11):1720-5. PubMed ID: 9171881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of novel opioid ligands with a C-homomorphinan skeleton.
    Ishikawa K; Mochizuki Y; Hirayama S; Nemoto T; Nagai K; Itoh K; Fujii H
    Bioorg Med Chem; 2016 May; 24(10):2199-205. PubMed ID: 27079125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole.
    Coop A; Rothman RB; Dersch C; Partilla J; Porreca F; Davis P; Jacobson AE; Rice KC
    J Med Chem; 1999 May; 42(9):1673-9. PubMed ID: 10229636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (E)- and (Z)-7-arylidenenaltrexones: synthesis and opioid receptor radioligand displacement assays.
    Palmer RB; Upthagrove AL; Nelson WL
    J Med Chem; 1997 Feb; 40(5):749-53. PubMed ID: 9057861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of spacer and address components in peptidomimetic delta opioid receptor antagonists related to naltrindole.
    Portoghese PS; Nagase H; MaloneyHuss KE; Lin CE; Takemori AE
    J Med Chem; 1991 May; 34(5):1715-20. PubMed ID: 1851846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophilic N-benzylnaltrindoles as delta opioid receptor-selective antagonists.
    Korlipara VL; Takemori AE; Portoghese PS
    J Med Chem; 1995 Apr; 38(8):1337-43. PubMed ID: 7731019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
    Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalently induced activation of the delta opioid receptor by a fluorogenic affinity label, 7'-(phthalaldehydecarboxamido)naltrindole (PNTI).
    Le Bourdonnec B; El Kouhen R; Poda G; Law PY; Loh HH; Ferguson DM; Portoghese PS
    J Med Chem; 2001 Mar; 44(7):1017-20. PubMed ID: 11297446
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
    Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
    J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
    Portoghese PS; Sultana M; Nagase H; Takemori AE
    Eur J Pharmacol; 1992 Jul; 218(1):195-6. PubMed ID: 1327826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-benzylnaltrindoles as long-acting delta-opioid receptor antagonists.
    Korlipara VL; Takemori AE; Portoghese PS
    J Med Chem; 1994 Jun; 37(12):1882-5. PubMed ID: 8021928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
    Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
    J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.